An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.
Crea F, Fornaro L, Paolicchi E, Masi G, Frumento P, Loupakis F, Salvatore L, Cremolini C, Schirripa M, Graziano F, Ronzoni M, Ricci V, Farrar WL, Falcone A, Danesi R.
Crea F, et al. Among authors: paolicchi e.
Ann Oncol. 2012 May;23(5):1207-1213. doi: 10.1093/annonc/mdr387. Epub 2011 Sep 16.
Ann Oncol. 2012.
PMID: 21926398
Free article.